• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织因子-蛋白酶激活受体 2 信号通路促进饮食诱导的肥胖和脂肪组织炎症。

Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation.

机构信息

Department of Cell Biology, Torrey Pines Institute for Molecular Studies, San Diego, California, USA.

出版信息

Nat Med. 2011 Oct 23;17(11):1490-7. doi: 10.1038/nm.2461.

DOI:10.1038/nm.2461
PMID:22019885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3210891/
Abstract

Tissue factor, the initiator of the coagulation cascade, mediates coagulation factor VIIa-dependent activation of protease-activated receptor 2 (PAR2). Here we delineate a role for this signaling pathway in obesity and its complications. Mice lacking PAR2 (F2rl1) or the cytoplasmic domain of tissue factor were protected from weight gain and insulin resistance induced by a high-fat diet. In hematopoietic cells, genetic ablation of tissue factor-PAR2 signaling reduced adipose tissue macrophage inflammation, and specific pharmacological inhibition of macrophage tissue factor signaling rapidly ameliorated insulin resistance. In contrast, nonhematopoietic cell tissue factor-VIIa-PAR2 signaling specifically promoted obesity. Mechanistically, adipocyte tissue factor cytoplasmic domain-dependent VIIa signaling suppressed Akt phosphorylation with concordant adverse transcriptional changes of key regulators of obesity and metabolism. Pharmacological blockade of adipocyte tissue factor in vivo reversed these effects of tissue factor-VIIa signaling and rapidly increased energy expenditure. Thus, inhibition of tissue factor signaling is a potential therapeutic avenue for improving impaired metabolism and insulin resistance in obesity.

摘要

组织因子是凝血级联反应的启动子,介导凝血因子 VIIa 依赖性蛋白酶激活受体 2(PAR2)的激活。在这里,我们描述了这种信号通路在肥胖及其并发症中的作用。缺乏 PAR2(F2rl1)或组织因子细胞质结构域的小鼠可防止高脂肪饮食引起的体重增加和胰岛素抵抗。在造血细胞中,组织因子-PAR2 信号的遗传缺失可减少脂肪组织巨噬细胞炎症,而巨噬细胞组织因子信号的特异性药理学抑制可迅速改善胰岛素抵抗。相比之下,非造血细胞组织因子-VIIa-PAR2 信号特异性促进肥胖。从机制上讲,脂肪细胞组织因子细胞质结构域依赖性 VIIa 信号抑制 Akt 磷酸化,同时肥胖和代谢关键调节因子的转录发生不良变化。体内药理学阻断组织因子可逆转组织因子-VIIa 信号的这些作用,并迅速增加能量消耗。因此,抑制组织因子信号可能是改善肥胖症中代谢受损和胰岛素抵抗的一种潜在治疗途径。

相似文献

1
Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation.组织因子-蛋白酶激活受体 2 信号通路促进饮食诱导的肥胖和脂肪组织炎症。
Nat Med. 2011 Oct 23;17(11):1490-7. doi: 10.1038/nm.2461.
2
Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice.造血组织因子-蛋白酶激活受体2信号传导促进肝脏炎症,并促成肥胖小鼠的糖异生和脂肪变性途径。
Am J Pathol. 2015 Feb;185(2):524-35. doi: 10.1016/j.ajpath.2014.10.008. Epub 2014 Dec 2.
3
Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism.饮食诱导的肥胖、脂肪炎症和与 PAR2 表达相关的代谢功能障碍可通过 PAR2 拮抗作用得到缓解。
FASEB J. 2013 Dec;27(12):4757-67. doi: 10.1096/fj.13-232702. Epub 2013 Aug 20.
4
Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.蛋白酶激活受体1和2信号传导在缺氧诱导血管生成中的作用
Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1456-62. doi: 10.1161/ATVBAHA.107.142539. Epub 2007 Mar 15.
5
Macrophage-Expressed Coagulation Factor VII Promotes Adverse Cardiac Remodeling.巨噬细胞表达的凝血因子 VII 促进不良的心脏重构。
Circ Res. 2024 Sep 27;135(8):841-855. doi: 10.1161/CIRCRESAHA.123.324114. Epub 2024 Sep 5.
6
Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.在抗磷脂综合征小鼠模型中,组织因子/凝血因子VIIa/蛋白酶激活受体2轴介导的中性粒细胞活化导致胎儿死亡。
J Clin Invest. 2008 Oct;118(10):3453-61. doi: 10.1172/JCI36089.
7
Tissue factor and obesity, a two-way street.组织因子与肥胖:一条双向道
Nat Med. 2011 Nov 7;17(11):1343-4. doi: 10.1038/nm.2551.
8
Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.通过蛋白酶激活受体 2 工程化组织因子.因子 VIIa 复合物信号传导的底物选择性。
J Biol Chem. 2010 Jun 25;285(26):19959-66. doi: 10.1074/jbc.M110.101030. Epub 2010 Apr 13.
9
Hippo-YAP/TAZ-ROS signaling axis regulates metaflammation induced by SelenoM deficiency in high-fat diet-derived obesity.河马-YAP/TAZ-ROS信号轴调节高脂饮食诱导的肥胖中硒蛋白M缺乏所引发的亚炎症反应。
J Adv Res. 2025 May;71:603-620. doi: 10.1016/j.jare.2024.06.005. Epub 2024 Jun 13.
10
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.恩格列净通过促进脂肪利用和棕色化以及通过极化 M2 巨噬细胞来减轻炎症和胰岛素抵抗,从而抑制 SGLT2。在饮食诱导肥胖的小鼠中。
EBioMedicine. 2017 Jun;20:137-149. doi: 10.1016/j.ebiom.2017.05.028. Epub 2017 May 26.

引用本文的文献

1
The Role of PAR2 in MASLD Progression and HCC Development.PAR2在代谢相关脂肪性肝病进展和肝癌发生中的作用
Int J Mol Sci. 2025 Jul 23;26(15):7076. doi: 10.3390/ijms26157076.
2
PAR2 regulates proliferation, migration of lung cancer and chemotherapy sensitivity by involving PTEN pathway.蛋白酶激活受体2(PAR2)通过磷脂酰肌醇-3,4,5-三磷酸酯酶(PTEN)途径调节肺癌的增殖、迁移及化疗敏感性。
Future Sci OA. 2025 Dec;11(1):2535221. doi: 10.1080/20565623.2025.2535221. Epub 2025 Jul 21.
3
The Many Faces of Protease-Activated Receptor 2 in Kidney Injury.

本文引用的文献

1
Increased tissue factor expression in diabetes mellitus type 2 monocytes caused by insulin resistance.胰岛素抵抗导致2型糖尿病单核细胞中组织因子表达增加。
J Thromb Haemost. 2011 Apr;9(4):873-5. doi: 10.1111/j.1538-7836.2011.04201.x.
2
Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.组织因子胞质结构域与 PAR2 信号在乳腺癌发展中的相互作用。
Blood. 2010 Dec 23;116(26):6106-13. doi: 10.1182/blood-2010-06-289314. Epub 2010 Sep 22.
3
Beta-arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-activated-receptor-2.
蛋白酶激活受体2在肾损伤中的多种表现
Biomedicines. 2025 Feb 8;13(2):414. doi: 10.3390/biomedicines13020414.
4
Protease activated receptor 2 as a novel druggable target for the treatment of metabolic dysfunction-associated fatty liver disease and cancer.蛋白酶激活受体 2 作为一种新的可药物治疗代谢功能障碍相关脂肪性肝病和癌症的靶点。
Front Immunol. 2024 Oct 11;15:1397441. doi: 10.3389/fimmu.2024.1397441. eCollection 2024.
5
Update on protease-activated receptor 2 in inflammatory and autoimmune dermatological diseases.蛋白酶激活受体 2 在炎症性和自身免疫性皮肤病中的研究进展。
Front Immunol. 2024 Sep 19;15:1449126. doi: 10.3389/fimmu.2024.1449126. eCollection 2024.
6
Venous thrombosis and obesity: from clinical needs to therapeutic challenges.静脉血栓形成与肥胖:从临床需求到治疗挑战
Intern Emerg Med. 2025 Jan;20(1):47-64. doi: 10.1007/s11739-024-03765-7. Epub 2024 Sep 13.
7
Par2-mediated responses in inflammation and regeneration: choosing between repair and damage.蛋白酶激活受体2介导的炎症与再生反应:在修复与损伤之间抉择
Inflamm Regen. 2024 May 30;44(1):26. doi: 10.1186/s41232-024-00338-1.
8
The thrombin receptor PAR4 supports visceral adipose tissue inflammation.凝血酶受体 PAR4 支持内脏脂肪组织炎症。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):7187-7200. doi: 10.1007/s00210-024-03097-5. Epub 2024 Apr 23.
9
Nonlinear Relationship Between Systemic Immune-Inflammation and Hepatic Steatosis: A Population-Based Study in China.全身免疫炎症与肝脂肪变性之间的非线性关系:一项基于中国人群的研究。
J Inflamm Res. 2024 Feb 3;17:711-720. doi: 10.2147/JIR.S440430. eCollection 2024.
10
Protease-activated receptor 2 attenuates doxorubicin-induced apoptosis in colon cancer cells.蛋白酶激活受体2减轻阿霉素诱导的结肠癌细胞凋亡。
J Cell Commun Signal. 2023 Dec;17(4):1293-1307. doi: 10.1007/s12079-023-00791-6. Epub 2023 Nov 22.
β-arrestin 抑制蛋白酶激活受体-2 下游钙调蛋白依赖性激酶激酶-β 依赖的 AMPK 激活。
BMC Biochem. 2010 Sep 21;11:36. doi: 10.1186/1471-2091-11-36.
4
GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.GPR120 是一种 omega-3 脂肪酸受体,具有强大的抗炎和胰岛素增敏作用。
Cell. 2010 Sep 3;142(5):687-98. doi: 10.1016/j.cell.2010.07.041.
5
Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.Sfrp5 是一种抗炎脂肪因子,可调节肥胖中的代谢功能障碍。
Science. 2010 Jul 23;329(5990):454-7. doi: 10.1126/science.1188280. Epub 2010 Jun 17.
6
Bisphenol A downregulates Akt signaling and inhibits adiponectin production and secretion in 3T3-L1 adipocytes.双酚 A 下调 Akt 信号通路并抑制 3T3-L1 脂肪细胞中脂联素的产生和分泌。
J Atheroscler Thromb. 2010 Aug 31;17(8):834-43. doi: 10.5551/jat.4051. Epub 2010 May 13.
7
Teaching old receptors new tricks: biasing seven-transmembrane receptors.旧受体新技巧:偏向七跨膜受体。
Nat Rev Drug Discov. 2010 May;9(5):373-86. doi: 10.1038/nrd3024.
8
Adiponectin: a key player in obesity related disorders.脂联素:肥胖相关疾病的关键因素。
Curr Pharm Des. 2010 Jun;16(17):1896-901. doi: 10.2174/138161210791208893.
9
Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen.结肠炎相关癌症依赖于止血和炎症系统之间的相互作用,并得到纤维蛋白原整合素 α(M)β(2)结合的支持。
Cancer Res. 2010 Apr 1;70(7):2634-43. doi: 10.1158/0008-5472.CAN-09-3465. Epub 2010 Mar 16.
10
Macrophages, inflammation, and insulin resistance.巨噬细胞、炎症与胰岛素抵抗。
Annu Rev Physiol. 2010;72:219-46. doi: 10.1146/annurev-physiol-021909-135846.